LONDON, Dec. 17, 2016 /PRNewswire/ -- KEY FINDINGS
Europe has the largest market share of In-vitro fertilization market. It pioneered the IVF technique and continuous research and development and investment has led to constant market growth. The global in-vitro fertilization market is poised to grow in 2016-2022 The various reasons for growth of the in-vitro fertilization market are increasing infertility across the world, delayed pregnancies, growing social acceptance of in-vitro fertilization, improving healthcare infrastructure and more awareness.
In-vitro fertilization refers to fertilization of egg with sperm outside the female body. It is a process the helps infertile couples have a child. WHO estimated that almost 25% couples in developing countries are infertile. There is a growing rate of infertility all over the globe. Reasons for infertility are increasing late marriages leading to higher maternal age, gynecological issues, growing incidences of obesity and addiction to alcohol, smoking and tobacco.
In-vitro fertilization market is segmented on the basis of geography, instruments, transfer techniques, procedure and end users. Various kinds of transfer techniques for IVF are fresh embryo transfer technique, frozen embryo transfer technique and donor egg transfer technique. IVF market is classified on the basis of IVF procedure and it can be either Intra cytoplasmic sperm injection (ICSI) or frozen embryo replacement (FER) or pre-implantation genetic diagnosis (PGD). IVF market is also classified on the basis of instruments used, which can be cryosystems, incubators, imaging systems, sperm separation systems, disposables and consumable ovum aspiration pump and others. End-users for IVF technology can be either hospitals or fertility clinics or surgical centers or clinical research institutes.
Market drivers for in-vitro fertilization are increasing rates of infertility all over the world, late pregnancies, social acceptance of in-vitro fertilization, growing awareness about this process, improving healthcare infrastructure and increase in healthcare expenditure.
Currently intra cytoplasmic sperm injection (ICSI) has the highest market share for IVF procedure and it is expected that it will continue to show good growth over the forecast period. Frozen embryo replacement (FER) will be the fastest growing segment during 2016-2022 due to higher success rates. FER has advantages like fewer miscarriages rate, increased implantation rate and low risk of pre-term labor.
Fresh non-donor embryo technique has the highest market share in the IVF market; IVF with ICSI is most widely used in case of fresh non-donor eggs followed by IVF without ICSI. Frozen non-donor market growth has the highest growth rate and will continue to have so in the forecast period. Fertility clinics are the largest end user accounting for 75% market share.
Factors that will restrain market growth are high costs associated with the procedure, low awareness in developing economies like Africa, ethical considerations and insufficient reimbursement policies for IVF treatment.
Download the full report: https://www.reportbuyer.com/product/4461527/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/europe-infertility-testing-and-treatment-market-forecast-2016-2022-300380436.html